Cargando…
Risk factors for cardiovascular disease in patients with metabolic-associated fatty liver disease: a machine learning approach
BACKGROUND: Nonalcoholic fatty liver disease is associated with an increased cardiovascular disease (CVD) risk, although the exact mechanism(s) are less clear. Moreover, the relationship between newly redefined metabolic-associated fatty liver disease (MAFLD) and CVD risk has been poorly investigate...
Autores principales: | Drożdż, Karolina, Nabrdalik, Katarzyna, Kwiendacz, Hanna, Hendel, Mirela, Olejarz, Anna, Tomasik, Andrzej, Bartman, Wojciech, Nalepa, Jakub, Gumprecht, Janusz, Lip, Gregory Y. H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9655870/ https://www.ncbi.nlm.nih.gov/pubmed/36371249 http://dx.doi.org/10.1186/s12933-022-01672-9 |
Ejemplares similares
-
Machine learning identification of risk factors for heart failure in patients with diabetes mellitus with metabolic dysfunction associated steatotic liver disease (MASLD): the Silesia Diabetes-Heart Project
por: Nabrdalik, Katarzyna, et al.
Publicado: (2023) -
Metabolic-Associated Fatty Liver Disease (MAFLD), Diabetes, and Cardiovascular Disease: Associations with Fructose Metabolism and Gut Microbiota
por: Drożdż, Karolina, et al.
Publicado: (2021) -
Machine learning profiles of cardiovascular risk in patients with diabetes mellitus: the Silesia Diabetes-Heart Project
por: Kwiendacz, Hanna, et al.
Publicado: (2023) -
Fat, Sugar or Gut Microbiota in Reducing Cardiometabolic Risk: Does Diet Type Really Matter?
por: Nabrdalik, Katarzyna, et al.
Publicado: (2021) -
Low Quantitative Blush Evaluator score predicts larger infarct size and reduced left ventricular systolic function in patients with STEMI regardless of diabetes status
por: Nabrdalik, Katarzyna, et al.
Publicado: (2023)